Nanomaterials in targeting cancer stem cells for cancer therapy

Frontiers in Pharmacology

Volumn 8, Issue JAN, 2017, Pages

  Qin, Weiwei ^a   Huang, Guan ^a   Chen, Zuanguang ^a   Zhang, Yuanqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cancer stem cells; Multidrug resistance; Nanomaterials; Targeted therapies; Unlimited proliferation

Indexed keywords

ABC TRANSPORTER; CAPECITABINE; CARBON NANOPARTICLE; CARBON NANOTUBE; CD133 ANTIGEN; CISPLATIN; CURCUMIN; DENDRIMER; DEXAMETHASONE; DISULFIRAM; DNA ORIGAMI; DOXORUBICIN; EPIRUBICIN; GLUCOSE TRANSPORTER 3; GOLD NANOPARTICLE; GOLD NANOROD; GRAPHENE OXIDE; HERMES ANTIGEN; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOSOME; MACROGOL; NANODIAMOND; NANOMATERIAL; POLYGLACTIN; POLYMER; SALINOMYCIN; SINGLE WALLED NANOTUBE; THY 1 ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOCOMPATIBILITY; BREAST CANCER; CANCER STEM CELL; CANCER THERAPY; CELL SUBPOPULATION; CELL SURVIVAL; DRUG DELIVERY SYSTEM; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LIVER CANCER; MELANOMA; MOLECULAR STABILITY; NONHUMAN; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; PROTEIN EXPRESSION; REVIEW; STEM CELL SELF-RENEWAL; STOMACH CANCER; SYNTHESIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 85012060198     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00001     Document Type: Review

References (140)

1. Ahmad, A., Mondal, S.K., Mukhopadhyay, D., Banerjee, R., and Alkharfy, K. M. (2016). Development of liposomal formulation for delivering anticancer drug to breast cancer stem-cell-like cells and its pharmacokinetics in an animal model. Mol. Pharm. 13, 1081-1088. doi: 10.1021/acs.molpharmaceut.5b00900
2. Al Faraj, A., Shaik, A. S., Al Sayed, B., Halwani, R., and Al Jammaz, I. (2016a). Specific targeting and noninvasive imaging of breast cancer stem cells using single-walled carbon nanotubes as novel multimodality nanoprobes. Nanomedicine 11, 31-46. doi: 10.2217/nnm.15.182
3. Al Faraj, A., Shaik, A. S., Ratemi, E., and Halwani, R. (2016b). Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model. J. Control. Release 225, 240-251. doi: 10.1016/j.jconrel.2016.01.053
4. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 3983-3988. doi: 10.1073/pnas.0530291100
5. Amreddy, N., Muralidharan, R., Babu, A., Mehta, M., Johnson, E. V., Zhao, Y. D., et al. (2015). Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy. Int. J. Nanomed. 10, 6773-6788. doi: 10.2147/IJN.S93237
6. Arabi, L., Badiee, A., Mosaffa, F., and Jaafari, M. R. (2015). Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin. J. Control. Release 220, 275-286. doi: 10.1016/j.jconrel.2015.10.044
7. Atkinson, R. L., Zhang, M., Diagaradjane, P., Peddibhotla, S., Contreras, A., Hilsenbeck, S. G., et al. (2010). Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci. Transl. Med. 2, 55ra79. doi: 10.1126/scitranslmed.3001447
8. Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760. doi: 10.1038/nature05236
9. Basak, S. K., Zinabadi, A., Wu, A. W., Venkatesan, N., Duarte, V. M., Kang, J. J., et al. (2015). Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells. Oncotarget 6, 18504-18517. doi: 10.18632/oncotarget.4181
10. Bild, A. H., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., et al. (2006). Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353-357. doi: 10.1038/nature04296
11. Bonnet, D., and Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737. doi: 10.1038/nm0797-730
12. Brannon-Peppas, L., and Blanchette, J. O. (2004). Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56, 1649-1659. doi: 10.1016/j.addr.2004.02.014
13. Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., et al. (2010). Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J. Am. Chem. Soc. 132, 4678-4684. doi: 10.1021/ja908117a
14. Burke, A. R., Singh, R. N., Carroll, D. L., Wood, J. C. S., D'Agostino, R. B. Jr., Ajayan, P. M., et al. (2012). The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials 33, 2961-2970. doi: 10.1016/j.biomaterials.2011.12.052
15. Chen, J., Liu, Q., Xiao, J., and Du, J. (2015). EpCAM-antibody-labeled noncytotoxic polymer vesicles for cancer stem cells-targeted delivery of anticancer drug and siRNA. Biomacromolecules 16, 1695-1705. doi: 10.1021/acs.biomac.5b00551
16. Chen, T., Xu, S., Zhao, T., Zhu, L., Li, Y., Zhang, H., et al. (2012). Gold nanocluster-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. ACS Appl. Mat. Interfaces 4, 5766-5774. doi: 10.1021/am301223n
17. Chen, Y. C., Huang, X. C., Luo, Y. L., Chang, Y. C., Hsieh, Y. Z., and Hsu, H. Y. (2013). Non-metallic nanomaterials in cancer theranostics: a review of silica-and carbon-based drug delivery systems. Sci. Technol. Adv. Mater. 14:44407. doi: 10.1088/1468-6996/14/4/044407
18. Chenna, V., Hu, C., Pramanik, D., Aftab, B. T., Karikari, C., Campbell, N. R., et al. (2012). A polymeric nanoparticle encapsulated small-molecule inhibitor of hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to smoothened antagonists. Mol. Cancer Ther. 11, 165-173. doi: 10.1158/1535-7163.MCT-11-0341
19. Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., and Maitland, N. J. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946-10951. doi: 10.1158/0008-5472.CAN-05-2018
20. Colson, Y. L., and Grinstaff, M. W. (2012). Biologically responsive polymeric nanoparticles for drug delivery. Adv. Mater. 24, 3878-3886. doi: 10.1002/adma.201200420
21. Conde, J., Oliva, N., and Artzi, N. (2015). Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance. Proc. Natl. Acad. Sci. U.S.A. 112, E1278-E1287. doi: 10.1073/pnas.1421229112
22. Conde, J., Oliva, N., Zhang, Y., and Artzi, N. (2016). Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat. Mater. 15, 1128-1138. doi: 10.1038/nmat4707
23. Crucho, C. I. (2015). Stimuli-responsive polymeric nanoparticles for nanomedicine. ChemMedChem 10, 24-38. doi: 10.1002/cmdc.201402290
24. Dean, M., Fojo, T., and Bates, S. (2005). Tumour stem cells and drug resistance. Nat. Rev. Cancer 5, 275-284. doi: 10.1038/nrc1590
25. Diao, J. J., and Cao, Q. (2011). Gold nanoparticle wire and integrated wire array for electronic detection of chemical and biological molecules. AIP Adv. 1, 012115. doi: 10.1063/1.3568815
26. Diehn, M., and Clarke, M. F. (2006). Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J. Natl. Cancer Inst. 98, 1755-1757. doi: 10.1093/jnci/djj505
27. Duncan, R., and Gaspar, R. (2011). Nanomedicine(s) under the microscope. Mol. Pharm. 8, 2101-2141. doi: 10.1021/mp200394t
28. Elbialy, N. S., Fathy, M. M., and Khalil, W. M. (2015). Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery. Int. J. Pharm. 490, 190-199. doi: 10.1016/j.ijpharm.2015.05.032
29. Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., et al. (2007). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15, 504-514. doi: 10.1038/sj.cdd.4402283
30. Eyler, C. E., and Rich, J. N. (2008). Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J. Clin. Oncol. 26, 2839-2845. doi: 10.1200/JCO.2007.15.1829
31. Fiorillo, M., Peiris-Pagés, M., Ozsvari, B., Gandara, R., Sotgia, F., Lisanti, M. P., et al. (2015). Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via "differentiation-based nano-therapy". Oncotarget 6, 3553-3562. doi: 10.18632/oncotarget.3348
32. Fukuda, K., Saikawa, Y., Ohashi, M., Kumagai, K., Kitajima, M., Okano, H., et al. (2009). Tumor initiating potential of side population cells in human gastric cancer. Int. J. Oncol. 34, 1201-1207. doi: 10.3892/ijo_00000248
33. Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., et al. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011-7021. doi: 10.1158/0008-5472.CAN-04-1364
34. Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., et al. (2003). Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155-1159. doi: 10.1126/science.1082504
35. Ghosh, P., Han, G., De, M., Kim, C. K., and Rotello, V. M. (2008). Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 60, 1307-1315. doi: 10.1016/j.addr.2008.03.016
36. Gilam, A., Conde, J., Weissglas-Volkov, D., Oliva, N., Friedman, E., Artzi, N., et al. (2016). Local microRNA delivery targets Palladin and prevents metastatic breast cancer. Nat. Commun. 7:12868. doi: 10.1038/ncomms12868
37. Gonçalves, G., Vila, M., Portolés, M. T., Vallet-Regi, M., Gracio, J., and Marques, P. A. (2013). Nano-graphene oxide: a potential multifunctional platform for cancer therapy. Adv. Healthc. Mater. 2, 1072-1090. doi: 10.1002/adhm.201300023
38. Gurunathan, S., Han, J. W., Park, J. H., Kim, E., Choi, Y.-J., Kwon, D.-N., et al. (2015). Reduced graphene oxide-silver nanoparticle nanocomposite: a potential anticancer nanotherapy. Int. J. Nanomed. 10, 6257-6276. doi: 10.2147/IJN.S92449
39. Hadinoto, K., Sundaresan, A., and Cheow, W. S. (2013). Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur. J. Pharm. Biopharm. 85, 427-443. doi: 10.1016/j.ejpb.2013.07.002
40. Halley, P. D., Lucas, C. R., McWilliams, E. M., Webber, M. J., Patton, R. A., Kural, C., et al. (2016). Daunorubicin-loaded DNA origami nanostructures circumvent drug-resistance mechanisms in a leukemia model. Small 12, 308-320. doi: 10.1002/smll.201502118
41. Hamburger, A. W., and Salmon, S. E. (1977). Primary bioassay of human tumor stem cells. Science 197, 461-463. doi: 10.1126/science.560061
42. Han, H. D., Byeon, Y., Jeon, H. N., and Shin, B. C. (2014). Enhanced localization of anticancer drug in tumor tissue using polyethylenimine-conjugated cationic liposomes. Nanoscale Res. Lett. 9, 1-6. doi: 10.1186/1556-276X-9-209
43. Helbok, A., Rangger, C., Von Guggenberg, E., Saba-Lepek, M., Radolf, T., Thurner, G., et al. (2012). Research article: targeting properties of peptide-modified radiolabeled liposomal nanoparticles. Nanomed. Nanotechnol. Biol. Med. 8, 112-118. doi: 10.1016/j.nano.2011.04.012
44. Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., et al. (2003). Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U.S.A. 100, 15178-15183. doi: 10.1073/pnas.2036535100
45. Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., et al. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323. doi: 10.1016/j.stem.2007.06.002
46. Hu, C., Niestroj, M., Yuan, D., Chang, S., and Chen, J. (2015). Treating cancer stem cells and cancer metastasis using glucose-coated gold nanoparticles. Int. J. Nanomed. 10, 2065-2077. doi: 10.2147/IJN.S72144
47. Huang, X., El-Sayed, I. H., Qian, W., and El-Sayed, M. A. (2006). Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128, 2115-2120. doi: 10.1021/ja057254a
48. Huang, X., and El-Sayed, M. A. (2010). Review article: gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy. J. Adv. Res. 1, 13-28. doi: 10.1016/j.jare.2010.02.002
49. Iodice, C., Cervadoro, A., Palange, A., Key, J., Aryal, S., Ramirez, M. R., et al. (2016). Enhancing photothermal cancer therapy by clustering gold nanoparticles into spherical polymeric nanoconstructs. Opt. Lasers Eng. 76, 74-81. doi: 10.1016/j.optlaseng.2015.04.017
50. Jana, N. R., Gearheart, L., and Murphy, C. J. (2001). Wet chemical synthesis of high aspect ratio cylindrical gold nanorods. J. Phys. Chem. B 105, 4065-4067. doi: 10.1021/jp0107964
51. Jiang, Q., Shi, Y., Zhang, Q., Li, N., Zhan, P., Song, L., et al. (2015). A self-assembled dna origami-gold nanorod complex for cancer theranostics. Small 11, 5134-5141. doi: 10.1002/smll.201501266
52. Jiang, Q., Song, C., Nangreave, J., Liu, X., Lin, L., Qiu, D. L., et al. (2012). DNA origami as a carrier for circumvention of drug resistance. J. Am. Chem. Soc. 134, 13396-13403. doi: 10.1021/ja304263n
53. Jung, H. S., Kong, W. H., Sung, D. K., Lee, M.-Y., Beack, S. E., Keum, D. H., et al. (2014). Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer. ACS Nano 8, 260-268. doi: 10.1021/nn405383a
54. Ke, X. Y., Lin Ng, V. W., Gao, S. J., Tong, Y. W., Hedrick, J. L., and Yang, Y. Y. (2014). Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials 35, 1096-1108. doi: 10.1016/j.biomaterials.2013.10.049
55. Kim, K. R., Bang, D., and Ahn, D. R. (2016). Nano-formulation of a photosensitizer using a DNA tetrahedron and its potential for in vivo photodynamic therapy. Biomater. Sci. 4, 605-609. doi: 10.1039/C5BM00467E
56. Kong, B., Zhu, A., Ding, C., Zhao, X., Li, B., and Tian, Y. (2012). Carbon dot-based inorganic-organic nanosystem for two-photon imaging and biosensing of pH variation in living cells and tissues. Adv. Mater. 24, 5844-5848. doi: 10.1002/adma.201202599
57. Kong, F., Zhang, H., Qu, X., Zhang, X., Chen, D., Ding, R., et al. (2016). Gold nanorods, DNA origami, and porous silicon nanoparticle-functionalized biocompatible double emulsion for versatile targeted therapeutics and antibody combination therapy. Adv. Mater. 28, 10195-10203. doi: 10.1002/adma.201602763
58. Kouri, F. M., Hurley, L. A., Daniel, W. L., Day, E. S., Hua, Y., Hao, L., et al. (2015). miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev. 29, 732-745. doi: 10.1101/gad.257394.114
59. Kumar, A., Ma, H., Zhang, X., Huang, K., Jin, S., Liu, J., et al. (2012). Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. Biomaterials 33, 1180-1189. doi: 10.1016/j.biomaterials.2011.10.058
60. Kumar, V., Mondal, G., Slavik, P., Rachagani, S., Batra, S. K., and Mahato, R. I. (2015). Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. Mol. Pharm. 12, 1289-1298. doi: 10.1021/mp500847s
61. Lang, S. H., Frame, F. M., and Collins, A. T. (2009). Prostate cancer stem cells. J. Pathol. 217, 299-306. doi: 10.1002/path.2478
62. Lanier, L. A., and Bermudez, H. (2015). DNA nanostructures: a shift from assembly to applications. Curr. Opin. Chem. Eng. 7, 93-100. doi: 10.1016/j.coche.2015.01.001
63. Lee, J. H., Yigit, M. V., Mazumdar, D., and Lu, Y. (2010). Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. Adv. Drug Deliv. Rev. 62, 592-605. doi: 10.1016/j.addr.2010.03.003
64. Lee, K., Drachev, V. P., and Irudayaraj, J. (2011). DNA-gold nanoparticle reversible networks grown on cell surface marker sites: application in diagnostics. ACS Nano 5, 2109-2117. doi: 10.1021/nn1030862
65. Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., et al. (2007). Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030-1037. doi: 10.1158/0008-5472.CAN-06-2030
66. Li, K., Qin, W., Li, F., Zhao, X., Jiang, B., Wang, K., et al. (2013). Nanoplasmonic imaging of latent fingerprints and identification of cocaine. Angew. Chem. Int. Edit. 52, 11542-11545. doi: 10.1002/anie.201305980
67. Li, K., Wang, K., Qin, W., Deng, S., Li, D., Shi, J., et al. (2015). DNA-directed assembly of gold nanohalo for quantitative plasmonic imaging of single-particle catalysis. J. Am. Chem. Soc. 137, 4292-4295. doi: 10.1021/jacs.5b00324
68. Li, Q., Liu, L., Liu, J.-W., Jiang, J.-H., Yu, R.-Q., and Chu, X. (2014). Nanomaterial-based fluorescent probes for live-cell imaging. TrAC Trends Anal. Chem. 58, 130-144. doi: 10.1016/j.trac.2014.03.007
69. Liu, K. K., Wang, C. C., Cheng, C. L., and Chao, J. I. (2009). Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells. Biomaterials 30, 4249-4259. doi: 10.1016/j.biomaterials.2009.04.056
70. Liu, Y., Yang, M., Zhang, J., Zhi, X., Li, C., Zhang, C., et al. (2014). Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo. Oncotarget 5, 7471-7485. doi: 10.18632/oncotarget.2166
71. Liu, Y., Yang, M., Zhang, C., Pan, F., Wang, K., Yang, Y., et al. (2016). Human induced pluripotent stem cells for tumor targeted delivery of gold nanorods and enhanced photothermal therapy. ACS Nano 10, 2375-2385. doi: 10.1021/acsnano.5b07172
72. Lokerse, W. J., Kneepkens, E. C., Ten Hagen, T. L., Eggermont, A. M., Grüll, H., and Koning, G. A. (2016). In depth study on thermosensitive liposomes: optimizing formulations for tumor specific therapy and in vitro to in vivo relations. Biomaterials 82, 138-150. doi: 10.1016/j.biomaterials.2015.12.023
73. Loo, C., Lowery, A., Halas, N., West, J., and Drezek, R. (2005). Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 5, 709-711. doi: 10.1021/nl050127s
74. Lu, W., Arumugam, S. R., Senapati, D., Singh, A. K., Arbneshi, T., Khan, S. A., et al. (2010). Multifunctional oval-shaped gold-nanoparticle-based selective detection of breast cancer cells using simple colorimetric and highly sensitive two-photon scattering assay. ACS Nano 4, 1739-1749. doi: 10.1021/nn901742q
75. Luo, W., Zhu, C., Su, S., Li, D., He, Y., Huang, Q., et al. (2010). Self-catalyzed, self-limiting growth of glucose oxidase-mimicking gold nanoparticles. ACS Nano 4, 7451-7458. doi: 10.1021/nn102592h
76. Maitland, N. J., and Collins, A. T. (2008). Prostate cancer stem cells: a new target for therapy. J. Clin. Oncol. 26, 2862-2870. doi: 10.1200/JCO.2007.15.1472
77. Malmsten, M. (2013). Inorganic nanomaterials as delivery systems for proteins, peptides, DNA, and siRNA. Curr. Opin. Colloid Interface Sci. 18, 468-480. doi: 10.1016/j.cocis.2013.06.002
78. Manchikanti, P., and Bandopadhyay, T. K. (2010). Nanomaterials and effects on biological systems: development of effective regulatory norms. Nanoethics 4, 77-83. doi: 10.1007/s11569-010-0084-9
79. Mandal, B., Bhattacharjee, H., Mittal, N., Sah, H., Balabathula, P., Thoma, L. A., et al. (2013). Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine 9, 474-491. doi: 10.1016/j.nano.2012.11.010
80. Murphy, C. J., Sau, T. K., Gole, A. M., Orendorff, C. J., Gao, J., Gou, L., et al. (2005). Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J. Phys. Chem. B 109, 13857-13870. doi: 10.1021/jp0516846
81. Ni, M. Z., Xiong, M., Zhang, X., Cai, G., Chen, H., Zeng, Q., et al. (2015). Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells. Int. J. Nanomed. 10, 2537-2554. doi: 10.2147/IJN.S78498
82. Nikoobakht, B., and El-Sayed, M. A. (2003). Preparation and growth mechanism of gold Nanorods (NRs) using seed-mediated growth method. Chem. Mater. 15, 1957-1962. doi: 10.1021/cm020732l
83. Novoselov, K. S., Geim, A. K., Morozov, S. V., Jiang, D., Zhang, Y., Dubonos, S. V., et al. (2004). Electric field effect in atomically thin carbon films. Science 306, 666. doi: 10.1126/science.1102896
84. O'Brien, C. A., Pollett, A., Gallinger, S., and Dick, J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110. doi: 10.1038/nature05372
85. Oli, M. (2010). Aptamer conjugated gold nanorods for targeted nanothermal radiation of Glioblastoma cancer cells (A novel selective targeted approach to cancer treatment). Young Sci. J. 3, 18-25. doi: 10.4103/0974-6102.68740
86. Orza, A., Olenic, L., Pruneanu, S., Pogacean, F., and Biris, A. S. (2010). Morphological and electrical characteristics of amino acid-AuNP nanostructured two-dimensional ensembles. Chem. Phys. 373, 295-299. doi: 10.1016/j.chemphys.2010.06.001
87. Orza, A., Soritau, O., Tomuleasa, C., Olenic, L., Florea, A., Pana, O., et al. (2013). Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles. Int. J. Nanomed. 8, 689-702. doi: 10.2147/IJN.S37481
88. Ouyang, X., Li, J., Liu, H., Zhao, B., Yan, J., Ma, Y., et al. (2013). Rolling circle amplification-based DNA origami nanostructrures for intracellular delivery of immunostimulatory drugs. Small 9, 3082-3087. doi: 10.1002/smll.201300458
89. Panyam, J., and Labhasetwar, V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329-347. doi: 10.1016/S0169-409X(02)00228-4
90. Patra, C. R., Bhattacharya, R., Mukhopadhyay, D., and Mukherjee, P. (2010). Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv. Drug Deliv. Rev. 62, 346-361. doi: 10.1016/j.addr.2009.11.007
91. Peng, C. A., and Wang, C. H. (2011). "CD133-positive cancer stem-like cells ablated by gold nanorod-mediated near-infrared laser treatment, " in Nanoelectronics Conference (INEC), 2011 IEEE 4th International (Tao-Yuan), 1-2.
92. Peng, T., Qin, W., Wang, K., Shi, J., Fan, C., and Li, D. (2015). Nanoplasmonic imaging of latent fingerprints with explosive RDX residues. Anal. Chem. 87, 9403-9407. doi: 10.1021/acs.analchem.5b02248
93. Qin, W. W., Wang, S. P., Li, J., Peng, T. H., Xu, Y., Wang, K., et al. (2015). Visualizing dopamine released from living cells using a nanoplasmonic probe. Nanoscale 7, 15070-15074. doi: 10.1039/C5NR04433B
94. Reya, T., Morrison, S. J., Clarke, M. F., and Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111. doi: 10.1038/35102167
95. Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., et al. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115. doi: 10.1038/nature05384
96. Setua, S., Ouberai, M., Welland, M., Piccirillo, S. G., and Watts, C. (2014). Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma. Nanoscale 6, 10865-10873. doi: 10.1039/C4NR03693J
97. Shao, W., Paul, A., Zhao, B., Lee, C., Rodes, L., and Prakash, S. (2013). Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model. Biomaterials 34, 10109-10119. doi: 10.1016/j.biomaterials.2013.09.007
98. Shen, K. Y., Liu, H. Y., Li, H. J., Wu, C. C., Liou, G. G., Chang, Y. C., et al. (2016). A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity. J. Control. Release 233, 57-63. doi: 10.1016/j.jconrel.2016.05.008
99. Shen, Y. A., Li, W. H., Chen, P. H., He, C. L., Chang, Y. H., and Chuang, C. M. (2015). Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol®-resistant ovarian cancer. Am. J. Transl. Res. 7, 841-855. Available online at: www.ajtr.org
100. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828.
101. Skrabalak, S. E., Chen, J., Sun, Y., Lu, X., Au, L., Cobley, C. M., et al. (2008). Gold nanocages: synthesis, properties, and applications. Acc. Chem. Res. 41, 1587-1595. doi: 10.1021/ar800018v
102. Stupp, R., and Hegi, M. E. (2007). Targeting brain-tumor stem cells. Nat. Biotechnol. 25, 193-194. doi: 10.1038/nbt0207-193
103. Sun, T., Wang, Y. C., Wang, F., Du, J. Z., Mao, C. Q., Sun, C. Y., et al. (2014a). Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds. Biomaterials 35, 836-845. doi: 10.1016/j.biomaterials.2013.10.011
104. Sun, T., Wang, Y., Wang, Y. C., Xu, J. B., Zhao, X., Vangveravong, S., et al. (2014b). Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies. Adv. Healthc. Mater. 3, 1283-1291. doi: 10.1002/adhm.201400026
105. Sun, Y., and Xia, Y. (2002). Shape-controlled synthesis of gold and silver nanoparticles. Science 298, 2176-2179. doi: 10.1126/science.1077229
106. Swaminathan, S. K., Roger, E., Toti, U., Niu, L., Ohlfest, J. R., and Panyam, J. (2013). CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer. J. Control. Release 171, 280-287. doi: 10.1016/j.jconrel.2013.07.014
107. Thompson, D. T. (2007). Using gold nanoparticles for catalysis. Nanotoday 2, 40-43. doi: 10.1016/S1748-0132(07)70116-0
108. Tian, B., Wang, C., Zhang, S., Feng, L., and Liu, Z. (2011). Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 5, 7000-7009. doi: 10.1021/nn201560b
109. Tian, F., Conde, J., Bao, C., Chen, Y., Curtin, J., and Cui, D. (2016). Gold nanostars for efficient in vitro and in vivo real-time SERS detection and drug delivery via plasmonic-tunable Raman/FTIR imaging. Biomaterials 106, 87-97. doi: 10.1016/j.biomaterials.2016.08.014
110. Tiloke, C., Phulukdaree, A., Anand, K., Gengan, R. M., and Chuturgoon, A. A. (2016). Moringa oleifera gold nanoparticles modulate oncogenes, tumor suppressor genes, and caspase-9 splice variants in A549 Cells. J. Cell. Biochem. 117, 2302-2314. doi: 10.1002/jcb.25528
111. Tomuleasa, C., Soritau, O., Orza, A., Dudea, M., Petrushev, B., Mosteanu, O., et al. (2012). Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells. J. Gastrointestin. Liver Dis. 21, 187-196.
112. Torchilin, V. P. (2006). Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 24, 1-16. doi: 10.1007/s11095-006-9132-0
113. Usacheva, M., Swaminathan, S. K., Kirtane, A. R., and Panyam, J. (2014). Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles. Mol. Pharm. 11, 3186-3195. doi: 10.1021/mp5003619
114. Wagstaff, A. J., Brown, S. D., Holden, M. R., Craig, G. E., Plumb, J. A., Brown, R. E., et al. (2012). Cisplatin drug delivery using gold-coated iron oxide nanoparticles for enhanced tumour targeting with external magnetic fields. Inorg. Chim. Acta 393, 328-333. doi: 10.1016/j.ica.2012.05.012
115. Wang, J., Sefah, K., Altman, M. B., Chen, T., You, M., Zhao, Z., et al. (2013). Aptamer-conjugated nanorods for targeted photothermal therapy of prostate cancer stem cells. Chem. Asian J. 8, 2417-2422. doi: 10.1002/asia.201300375
116. Wang, L., Liu, Y., Li, W., Jiang, X. M., Ji, Y. L., Wu, X. C., et al. (2011). Selective Targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett. 11, 772-780. doi: 10.1021/nl103992v
117. Wang, X., Low, X. C., Hou, W., Abdullah, L. N., Toh, T. B., Rashid, M. M. A., et al. (2014). Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells. ACS Nano 8, 12151-12166. doi: 10.1021/nn503491e
118. Wang, Z., Zhang, J., Ekman, J. M., Kenis, P. J., and Lu, Y. (2010). DNA-Mediated control of metal nanoparticle shape: one-pot synthesis and cellular uptake of highly stable and functional gold nanoflowers. Nano Lett. 10, 1886-1891. doi: 10.1021/nl100675p
119. Wei, X., Senanayake, T. H., Warren, G., and Vinogradov, S. V. (2013). Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of cd44-positive and drug-resistant tumors. Bioconjugate Chem. 24, 658-668. doi: 10.1021/bc300632w
120. Whitesides, G. M., Mathias, J. P., and Seto, C. T. (1991). Molecular self-assembly and nanochemistry: a chemical strategy for the synthesis of nanostructures. Science 254, 1312. doi: 10.1126/science.1962191
121. Wu, H., Shi, H., Zhang, H., Wang, X., Yang, Y., Yu, C., et al. (2014). Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery. Biomaterials 35, 5369-5380. doi: 10.1016/j.biomaterials.2014.03.038
122. Xia, Y., Li, W., Cobley, C. M., Chen, J., Xia, X., Zhang, Q., et al. (2011). Gold nanocages: from synthesis to theranostic applications. Acc. Chem. Res. 44, 914-924. doi: 10.1021/ar200061q
123. Xia, Y., Xiong, Y., Lim, B., and Skrabalak, S. E. (2009). Shape-controlled synthesis of metal nanocrystals: simple chemistry meets complex physics? Angew. Chem. Int. Edit. 48, 60-103. doi: 10.1002/anie.200802248
124. Xia, Z., Wang, P., Liu, X., Liu, T., Yan, Y., Yan, J., Zhong, J., Sun, G., He, D., et al. (2016). Tumor-penetrating peptide-modified DNA tetrahedron for targeting drug delivery. Biochemistry 55, 1326-1331. doi: 10.1021/acs.biochem.5b01181
125. Xie, J., Zhang, Q., Lee, J. Y., and Wang, D. I. (2008). The synthesis of SERS-active gold nanoflower tags for in vivo applications. ACS Nano 2, 2473-2480. doi: 10.1021/nn800442q
126. Xu, C. F., Liu, Y., Shen, S., Zhu, Y. H., and Wang, J. (2015). Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy. Biomaterials 51, 1-11. doi: 10.1016/j.biomaterials.2015.01.068
127. Xu, Y., Li, K., Qin, W., Zhu, B., Zhou, Z., Shi, J., et al. (2015). Unraveling the role of hydrogen peroxide in a-synuclein aggregation using an ultrasensitive nanoplasmonic probe. Anal. Chem. 87, 1968-1973. doi: 10.1021/ac5043895
128. Xu, Y., Chenna, V., Hu, C., Sun, H. X., Khan, M., Bai, H., et al. (2012). Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma. Clin. Cancer Res. 18, 1291-1302. doi: 10.1158/1078-0432.CCR-11-0950
129. Xu, Y., Wang, J., Li, X., Liu, Y., Dai, L., Wu, X., et al. (2014). Selective inhibition of breast cancer stem cells by gold nanorods mediated plasmonic hyperthermia. Biomaterials 35, 4667-4677. doi: 10.1016/j.biomaterials.2014.02.035
130. Yao, H. J., Zhang, Y. G., Sun, L., and Liu, Y. (2014). The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells. Biomaterials 35, 9208-9223. doi: 10.1016/j.biomaterials.2014.07.033
131. Yi, Y., Kim, H. J., Mi, P., Zheng, M., Takemoto, H., Toh, K., et al. (2016). Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles. J. Control Release 244, 247-256. doi: 10.1016/j.jconrel.2016.08.041
132. You, J., Zhao, J., Wen, X., Wu, C., Huang, Q., Guan, F., et al. (2015). Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles. J. Control. Release 202, 40-48. doi: 10.1016/j.jconrel.2015.01.031
133. Yuan, Y., Zhao, Y., Wu, N., Wen, J., Chen, L., Wei, Y., et al. (2013). A novel pegylated liposome-encapsulated SANT75 suppresses tumor growth through inhibiting hedgehog signaling pathway. PLoS ONE 8:e60266. doi: 10.1371/journal.pone.0060266
134. Zhang, Q., Jiang, Q., Li, N., Dai, L., Liu, Q., Song, L., et al. (2014). DNA origami as an in vivo drug delivery vehicle for cancer therapy. ACS Nano 8, 6633-6643. doi: 10.1021/nn502058j
135. Zhang, Y., Cui, Z., Kong, H., Xia, K., Pan, L., Li, J., et al. (2016). One-shot immunomodulatory nanodiamond agents for cancer immunotherapy. Adv. Mater. 28, 2699-2708. doi: 10.1002/adma.201506232
136. Zhao, L., Xu, Y. H., Akasaka, T., Abe, S., Komatsu, N., Watari, F., et al. (2014). Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells. Biomaterials 35, 5393-5406. doi: 10.1016/j.biomaterials.2014.03.041
137. Zhao, Y. X., Shaw, A., Zeng, X., Benson, E., Nyström, A. M., and Högberg, B. (2012). DNA origami delivery system for cancer therapy with tunable release properties. ACS Nano 6, 8684-8691. doi: 10.1021/nn3022662
138. Zheng, X., Liu, Q., Jing, C., Li, Y., Li, D., Luo, W., et al. (2011). Catalytic gold nanoparticles for nanoplasmonic detection of DNA hybridization. Angew. Chem. Int. Edit. 50, 11994-11998. doi: 10.1002/anie.201105121
139. Zhu, G., Zheng, J., Song, E., Donovan, M., Zhang, K., Liu, C., et al. (2013). Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc. Natl. Acad. Sci. U.S.A. 110, 7998-8003. doi: 10.1073/pnas.1220817110
140. Zhuang, X., Ma, X., Xue, X., Jiang, Q., Song, L., Dai, L., et al. (2016). A photosensitizer-loaded DNA origami nanosystem for photodynamic therapy. ACS Nano 10, 3486-3495. doi: 10.1021/acsnano.5b07671